Amerikanische Gesellschaft für Hirudotherapie

Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches

Genome and transcriptome paper published in BMC Genomics (2020)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSpeichel-PharmakologieBabenko VV et al. · BMC Genomics, 2020

Abstract

BACKGROUND: Salivary cell secretion (SCS) plays a critical role in blood feeding by medicinal leeches, making them of use for certain medical purposes even today. RESULTS: We annotated the Hirudo medicinalis genome and performed RNA-seq on salivary cells isolated from three closely related leech species, H. medicinalis, Hirudo orientalis, and Hirudo verbana. Differential expression analysis verified by proteomics identified salivary cell-specific gene expression, many of which encode previously unknown salivary components. However, the genes encoding known anticoagulants have been found to be expressed not only in salivary cells. The function-related analysis of the unique salivary cell genes enabled an update of the concept of interactions between salivary proteins and components of haemostasis. CONCLUSIONS: Here we report a genome draft of Hirudo medicinalis and describe identification of novel salivary proteins and new homologs of genes encoding known anticoagulants in transcriptomes of three medicinal leech species. Our data provide new insights in genetics of blood-feeding lifestyle in leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsAnticoagulantsGene Expression ProfilingGene Expression RegulationGenomeHirudo medicinalisLeechesProteomicsSalivaSalivary Proteins and Peptides

Zusammenfassung

First draft genome of Hirudo medicinalis with comparative salivary cell RNA-seq across H. medicinalis, H. orientalis, and H. verbana; differential expression analysis revealed many previously unknown salivary proteins and new homologs of anticoagulants expressed beyond salivary cells.

Warum dies für die Hirudotherapie relevant ist

This study annotated a draft genome of Hirudo medicinalis and performed RNA-seq on salivary cells from H. medicinalis, H. orientalis, and H. verbana, validated by proteomics, identifying salivary cell-specific genes including novel secreted proteins and new homologs of known anticoagulant genes. Notably, genes encoding known anticoagulants were also expressed outside salivary cells, and the authors updated the model of salivary protein–haemostasis interactions. For ASH, this is highly relevant as it expands the genetic catalogue of leech-derived bioactive secreted proteins that underpin the therapeutic basis of hirudotherapy. Honest caveat: the work is genomic/transcriptomic and discovery-oriented; no functional bioassays or clinical data are included, and therapeutic implications are inferential.

Zitation

Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches.

Babenko VV et al. · BMC Genomics, 2020

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.